| Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants KA Marr, F Crippa, W Leisenring, M Hoyle, M Boeckh, SA Balajee, ... Blood 103 (4), 1527-1533, 2004 | 528 | 2004 |
| Aspergillus Galactomannan Enzyme Immunoassay and Quantitative PCR for Diagnosis of Invasive Aspergillosis with Bronchoalveolar Lavage Fluid B Musher, D Fredricks, W Leisenring, SA Balajee, C Smith, KA Marr Journal of clinical microbiology 42 (12), 5517-5522, 2004 | 370 | 2004 |
| Contagious acute gastrointestinal infections DM Musher, BL Musher New England Journal of Medicine 351 (23), 2417-2427, 2004 | 249 | 2004 |
| Results from a phase IIb, randomized, multicenter study of GVAX pancreas and CRS-207 compared with chemotherapy in adults with previously treated metastatic pancreatic … DT Le, VJ Picozzi, AH Ko, ZA Wainberg, H Kindler, A Wang-Gillam, ... Clinical Cancer Research 25 (18), 5493-5502, 2019 | 232 | 2019 |
| Preoperative treatment of locally advanced rectal cancer D Schrag, Q Shi, MR Weiser, MJ Gollub, LB Saltz, BL Musher, J Goldberg, ... New England Journal of Medicine 389 (4), 322-334, 2023 | 117 | 2023 |
| Pancreatic cancer disparities in African Americans SN Khawja, S Mohammed, EJ Silberfein, BL Musher, WE Fisher, ... Pancreas 44 (4), 522-527, 2015 | 100 | 2015 |
| A phase 3 randomized clinical trial of chemotherapy with or without algenpantucel-L (hyperacute-pancreas) immunotherapy in subjects with borderline resectable or locally … DB Hewitt, N Nissen, H Hatoum, B Musher, J Seng, AL Coveler, ... Annals of Surgery 275 (1), 45-53, 2022 | 56 | 2022 |
| Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal … DM Musher, H Ceasar, EM Kojic, BL Musher, JC Gathe Jr, ... The Journal of infectious diseases 191 (7), 1063-1067, 2005 | 47 | 2005 |
| Adjuvant nab-paclitaxel+ gemcitabine in resected pancreatic ductal adenocarcinoma: results from a randomized, open-label, phase III trial MA Tempero, U Pelzer, EM O'Reilly, J Winter, DY Oh, CP Li, G Tortora, ... Journal of Clinical Oncology 41 (11), 2007, 2023 | 46 | 2023 |
| Oncolytic viral therapy for pancreatic cancer A Rahal, B Musher Journal of Surgical Oncology 116 (1), 94-103, 2017 | 45 | 2017 |
| Cost-effectiveness and diagnostic effectiveness analyses of multiple algorithms for the diagnosis of Lynch syndrome M Gould-Suarez, HB El-Serag, B Musher, LM Franco, GJ Chen Digestive diseases and sciences 59, 2913-2926, 2014 | 38 | 2014 |
| Patient-reported outcomes during and after treatment for locally advanced rectal cancer in the PROSPECT trial (Alliance N1048) E Basch, AC Dueck, SA Mitchell, H Mamon, M Weiser, L Saltz, M Gollub, ... Journal of Clinical Oncology 41 (21), 3724-3734, 2023 | 37 | 2023 |
| Rising incidence of colorectal cancer among young Hispanics in Texas DY Wang, AP Thrift, N Zarrin-Khameh, A Wichmann, GN Armstrong, ... Journal of clinical gastroenterology 51 (1), 34-42, 2017 | 30 | 2017 |
| Evaluation of Circulating Tumor DNA for Methylated BCAT1 and IKZF1 to Detect Recurrence of Stage II/Stage III Colorectal Cancer (CRC) BL Musher, JE Melson, G Amato, D Chan, M Hill, I Khan, ... Cancer Epidemiology, Biomarkers & Prevention 29 (12), 2702-2709, 2020 | 27 | 2020 |
| Prognostic value of nodal response after preoperative treatment of gastric adenocarcinoma YH Sada, BG Smaglo, JC Tan, HST Cao, BL Musher, NN Massarweh Journal of the National Comprehensive Cancer Network 17 (2), 161-168, 2019 | 19 | 2019 |
| Prognostic value of neoadjuvant treatment response in locally advanced rectal cancer YH Sada, HST Cao, GJ Chang, A Artinyan, BL Musher, BG Smaglo, ... Journal of Surgical Research 226, 15-23, 2018 | 17 | 2018 |
| A phase I trial targeting advanced or metastatic pancreatic cancer using a combination of standard chemotherapy and adoptively transferred nonengineered, multiantigen specific … BG Smaglo, BL Musher, S Vasileiou, M Kuvalekar, A Watanabe, ... Journal of Clinical Oncology 38 (15_suppl), 4622-4622, 2020 | 16 | 2020 |
| A phase I/II study of LOAd703, a TMZ-CD40L/4-1BBL-armed oncolytic adenovirus, combined with nab-paclitaxel and gemcitabine in advanced pancreatic cancer. BL Musher, BG Smaglo, W Abidi, M Othman, K Patel, S Jawaid, J Jing, ... Journal of Clinical Oncology 40 (16_suppl), 4138-4138, 2022 | 15 | 2022 |
| Evaluating treatment patterns for small cell carcinoma of the colon using the National Cancer Database (NCDB) S Balasubramanyam, BP O’Donnell, BL Musher, PM Jhaveri, MS Ludwig Journal of gastrointestinal cancer 50, 244-253, 2019 | 15 | 2019 |
| A phase I/II study combining a TMZ-CD40L/4-1BBL-armed oncolytic adenovirus and nab-paclitaxel/gemcitabine chemotherapy in advanced pancreatic cancer: An interim report. BL Musher, BG Smaglo, W Abidi, M Othman, K Patel, J Jing, N Stanietzky, ... Journal of Clinical Oncology 38 (4_suppl), 716-716, 2020 | 13 | 2020 |
